Cited by 908Liver Disease and TransplantationSepsis Diagnosis and TreatmentGut microbiota and health

The DOI matches its Crossref record; 164 of the 165 references it cites were found in a registry or an index.

Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

Open access

Jalan, Rajiv, Fernandez, Javier, Wiest, Reiner, Schnabl, Bernd, Moreau, Richard, Angeli, Paolo, Stadlbauer, Vanessa, Gustot, Thierry, Bernardi, Mauro, Canton, Rafael, Albillos, Agustin, Lammert, Frank, Wilmer, Alexander, Mookerjee, Rajeshwar, Vila, Jordi, Garcia-Martinez, Rita, Wendon, Julia, Such, José, Cordoba, Juan, Sanyal, Arun, Garcia-Tsao, Guadalupe, Arroyo, Vicente, Burroughs, Andrew, Ginès, Pere·2014·Journal of Hepatology

DOI 10.1016/j.jhep.2014.01.024

Open this paper in CoChat — free account

Abstract

Bacterial infections are very common and represent one of the most important reasons of progression of liver failure, development of liver-related complications, and mortality in patients with cirrhosis. In fact, bacterial infections may be a triggering factor for the occurrence of gastrointestinal bleeding, hypervolemic hyponatremia, hepatic encephalopathy, kidney failure, and development of acute-on-chronic liver failure. Moreover, infections are a very common cause of repeated hospitalizations, impaired health-related quality of life, and increased healthcare costs in cirrhosis. Bacterial infections develop as a consequence of immune dysfunction that occurs progressively during the course of cirrhosis. In a significant proportion of patients, infections are caused by gram-negative bacteria from intestinal origin, yet gram-positive bacteria are a frequent cause of infection, particularly in hospitalized patients. In recent years, infections caused by multidrug-resistant bacteria are becoming an important clinical problem in many countries. The reduction of the negative clinical impact of infections in patients with cirrhosis may be achieved by a combination of prophylactic measures, such as administration of antibiotics, to reduce the occurrence of infections in high-risk groups together with early identification and management of infection once it has developed. Investigation on the mechanisms of altered gut microflora, translocation of bacteria, and immune dysfunction may help develop more effective and safe methods of prevention compared to those that are currently available. Moreover, research on biomarkers of early infection may be useful in early diagnosis and treatment of infections. The current manuscript reports an in-depth review and a position statement on bacterial infections in cirrhosis.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2014.01.024

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
Moreau, R., Jalan, R., Ginès, P., Pavesi, M., Angeli, P., Córdoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,041
Self-citation
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
de Franchis, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.004 · Cited by 2,291
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942

Flagged first, then by citations

Show all 165 references

1 of the 165 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Bone, 2009, Chest, 136, 864
Zapater, 2007, Presence of bacterial DNA is a new survival indicator in patients with cirrhosis and non-infected ascitic fluid, Hepatology, 46, A40

Sorted by citations

Items 201–300 of 908

Antibiotics and Liver Cirrhosis: What the Physicians Need to Know
Zoratti, C., Moretti, R., Rebuzzi, L., Albergati, I. V., Somma, A. D., Decorti, G., Bella, S. D., Crocè, L. S., & Giuffrè, M. (2021) · Antibiotics · doi:10.3390/antibiotics11010031 · Cited by 35
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease – A Population-based Cohort Study
Ebrahimi, F., Simon, T. G., Hagström, H., Söderling, J. K., Wester, A., Roelstraete, B., & Ludvigsson, J. F. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.05.013 · Cited by 34
Antimicrobial Activity and Modulatory Effect of Essential Oil from the Leaf of Rhaphiodon echinus (Nees & Mart) Schauer on Some Antimicrobial Drugs
Duarte, A. E., de Menezes, I. R. A., Morais‐Braga, M. F. B., Leite, N. F., Barros, L. M., Waczuk, E. P., da Silva, M. P., Boligon, A. A., da Rocha, J. B. T., Souza, D. O., et al. (2016) · Molecules · doi:10.3390/molecules21060743 · Cited by 34
Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis
Soni, H., Kumar, P. M., Sharma, V., Bellam, B. L., Mishra, S., Mahendru, D., Mandavdhare, H. S., Medhi, B., Dutta, U., & Singh, V. (2020) · Hepatology International · doi:10.1007/s12072-020-10025-1 · Cited by 32
Afebrile Bacteremia in Adult Emergency Department Patients with Liver Cirrhosis: Clinical Characteristics and Outcomes
Chen, H., & Hsu, Y.-C. (2020) · Scientific Reports · doi:10.1038/s41598-020-64644-7 · Cited by 32
Diagnosis and treatment of ascites
Tsochatzis, E. A., & Gerbes, A. L. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.011 · Cited by 32
High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis
Agiasotelli, D., Alexopoulou, A., Vasilieva, L., Hadziyannis, E., Goukos, D., Daikos, G. L., & Dourakis, S. P. (2017) · Liver International · doi:10.1111/liv.13264 · Cited by 31
Post-liver transplantation patient experience
Kaplan, A. J., Korenjak, M., & Brown, R. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.008 · Cited by 31
Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management
Battle, A. R., Mudd, J., Ahlenstiel, G., & Kalo, E. (2025) · Livers · doi:10.3390/livers5030028 · Cited by 32
A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis
Wang, T., Yan, M., Tang, D., Xue, L., Zhang, T., Dong, Y., Zhu, L., Wang, X., & Dong, Y. (2018) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12724 · Cited by 31
Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection
Fujita, K., Kuroda, N., Morishita, A., Oura, K., Tadokoro, T., Nomura, T., Yoneyama, H., Arai, T., Himoto, T., Watanabe, S., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090267 · Cited by 31
Spontaneous bacterial peritonitis – therapeutic challenges in the era of increasing drug resistance of bacteria
Rostkowska, K., Szymanek-Pasternak, A., & Simon, K. A. (2018) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2018.80123 · Cited by 32
Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity
Riva, A., Palma, E., Devshi, D., Corrigall, D., Adams, H., Heaton, N. D., Menon, K., Preziosi, M., Zamalloa, A., Miquel, R., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.632502 · Cited by 31
Impact of preoperative infection on outcome after liver transplantation
Bertuzzo, V. R., Giannella, M., Cucchetti, A., Pinna, A. D., Grossi, A., Ravaioli, M., Gaudio, M. D., Cristini, F., Viale, P., & Cescon, M. (2017) · British journal of surgery · doi:10.1002/bjs.10449 · Cited by 31
Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis
Cai, Z., Fan, C., Zheng, J.-F., Zhang, X., Zhao, W., Li, B., Li, L., Dong, P., & Ding, H. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0776-4 · Cited by 30
Macrophage activation marker, soluble CD 163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection
Tornai, T., Vitális, Z., Sipeki, N., Dinya, T., Tornai, D., Antal‐Szalmás, P., Karányi, Z., Tornai, I., & Papp, M. (2016) · Liver International · doi:10.1111/liv.13133 · Cited by 30
Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients
Wu, Y., Wang, M.-F., Zhu, Y., & Lin, S. (2016) · Medicine · doi:10.1097/md.0000000000005127 · Cited by 30
Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial
Yim, H. J., Suh, S. J., Jung, Y. K., Yim, S. Y., Seo, Y. S., Lee, Y. R., Park, S. Y., Jang, J. Y., Kim, Y. S., Kim, H. S., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0168-7 · Cited by 30
Predictive model of mortality in patients with spontaneous bacterial peritonitis
Poca, M., Alvarado‐Tápias, E., Concepción, M., Pérez‐Cameo, C., Cañete, N., Gich, I. J., Romero, C., Casas, M., Román, E. M., Castells, L., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13745 · Cited by 30
Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art
Facciorusso, A., Antonino, M., Orsitto, E., & Sacco, R. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1644167 · Cited by 29
Ischaemia‐modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis
Giannone, F. A., Domenicali, M., Baldassarre, M., Bartoletti, M., Naldi, M., Laggetta, M., Bertucci, C., Colecchia, A., Viale, P., Bernardi, M., et al. (2015) · Liver International · doi:10.1111/liv.12860 · Cited by 29
Self-citation
Catenibacterium mitsuokai promotes hepatocellular carcinogenesis by binding to hepatocytes and generating quinolinic acid
Zhang, Y., Liu, W., Wong, C. C., Song, Q., Zhang, X., Zhou, Q., Ren, X., Ren, X., Xuan, R., Zhao, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.09.001 · Cited by 29
Bacterial infections in acute variceal hemorrhage despite antibiotics—a multicenter study of predictors and clinical impact
Lee, S., Saxinger, L. M., Ma, M. M., Prado, V., Fernández, J. C., Kumar, D., Abraldeṣ, J. G., Keough, A., Bastiampillai, R., Carbonneau, M., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617704564 · Cited by 29
Spontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatments
Fiore, M., Franco, S. D., Alfieri, A., Passavanti, M. B., Pace, M. C., Kelly, M. E., Damiani, G. B., & Leone, S. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1621167 · Cited by 28
Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA)
Testino, G., Vignoli, T., Patussi, V., Scafato, E., & Caputo, F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.09.017 · Cited by 28
A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure
Sun, J., Guo, H., Yu, X., Zhu, H., Zhang, X., Yang, J., Wang, J., Qian, Z., Shen, Z., Mao, R., et al. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-02007-w · Cited by 28
Spontaneous Bacterial Peritonitis in Decompensated Liver Cirrhosis—A Literature Review
Huang, C., Lee, C., & Chang, C. C. (2022) · Livers · doi:10.3390/livers2030018 · Cited by 30
Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
Bellafante, D., Gioia, S., Faccioli, J., Riggio, O., Ridola, L., & Nardelli, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031187 · Cited by 28
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
Simbrunner, B., Hartl, L., Jachs, M., Bauer, D. J. M., Scheiner, B., Hofer, B., Stättermayer, A. F., Marculescu, R., Trauner, M. A., Mandorfer, M., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100712 · Cited by 28
Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease
Qu, J., Feng, P., Luo, Y., & Lu, X. (2016) · Medicine · doi:10.1097/md.0000000000004270 · Cited by 28
Treatment of severe alcoholic hepatitis: past, present and future
Lanthier, N., & Stärkel, P. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12767 · Cited by 28
Acute kidney injury in liver transplant candidates: a position paper on behalf of the Liver Intensive Care Group of Europe
Angeli, P., Bezinover, D., Biancofiore, G., Bienholz, A., Findlay, J. Y., Paugam‐Burtz, C., Reyntjens, K. M. E. M., Sakai, T., Saner, F. H., Tomescu, D. R., et al. (2017) · Minerva Anestesiologica · doi:10.23736/s0375-9393.16.11661-x · Cited by 28
Self-citation
Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
Papp, M., Tornai, T., Vitális, Z., Tornai, I., Tornai, D., Dinya, T., Sümegi, A., & Antal‐Szalmás, P. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9172 · Cited by 28
Toward a Better Definition of Acute-on-Chronic Liver Failure
Duseja, A. K., & Singh, S. P. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.05.002 · Cited by 27
Spontaneous bacteremia and spontaneous bacterial peritonitis share similar prognosis in patients with cirrhosis: a cohort study
Marciano, S., Dirchwolf, M., Bermúdez, C., Sobenko, N., Haddad, L., Bert, F., Barcán, L., Smud, A., Posadas‐Martínez, M. L., Giunta, D. H., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9837-7 · Cited by 27
NUTRIC and Modified NUTRIC are Accurate Predictors of Outcome in End-Stage Liver Disease: A Validation in Critically Ill Patients with Liver Cirrhosis
Mayr, U., Pfau, J., Lukas, M., Bauer, U., Herner, A., Rasch, S., Schmid, R. M., Huber, W., Lahmer, T., & Batres-Baires, G. (2020) · Nutrients · doi:10.3390/nu12072134 · Cited by 29
Practice guidance for the use of terlipressin for liver cirrhosis–related complications
Qi, X., Bai, Z., Zhu, Q., Cheng, G., Chen, Y., Dang, X., Ding, H., Han, J., Han, L., He, Y., et al. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221098253 · Cited by 26
Noninvasive assessment of hepatic decompensation
Thiele, M. S., Johansen, S., Israelsen, M. E., Trebicka, J., Abraldeṣ, J. G., Ginès, P., & Krag, A. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000618 · Cited by 27
Self-citation
New antibiotic strategies in patients with cirrhosis and bacterial infection
Fernández, J., & Acevedo, J. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1100075 · Cited by 27
Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis
Miozzo, S. A. D. S., John, J. A., da Silva, M. C. A., Dossin, I. D. A., Tovo, C. V., & de Mattos, Â. A. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i35.1278 · Cited by 27
Management of bacterial infection in the liver transplant candidate
Ferrarese, A., Zanetto, A., Becchetti, C., Sciarrone, S. S., Shalaby, S., Germani, G., Gambato, M., Russo, F. P., Burra, P., & Senzolo, M. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i2.222 · Cited by 27
Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis
Ardolino, E., Wang, S. S., & Patwardhan, V. R. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05519-4 · Cited by 27
Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis
Bajaj, J. S., Tandon, P., O’Leary, J. G., Wong, F. S.-H., Biggins, S. W., García–Tsao, G., Kamath, P. S., Maliakkal, B. J., Fallon, M. B., Lai, J. C., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000044 · Cited by 27
Infection in cirrhosis: A prospective study
Bhattacharya, C., Das-Mondal, M., Gupta, D., Sarkar, A. K., KarPurkayastha, S., & Konar, A. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.07.010 · Cited by 26
Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature
Zaccherini, G., Tufoni, M., & Bernardi, M. (2020) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s264231 · Cited by 28
Self-citation
The synergy of dietary supplements Lactobacillus salivarius LI01 and Bifidobacterium longum TC01 in alleviating liver failure in rats treated with d -galactosamine
Zhuge, A., Li, S., Yuan, Y., Li, B., & Li, L. (2021) · Food & Function · doi:10.1039/d1fo01807h · Cited by 26
Novel prevention strategies for bacterial infections in cirrhosis
Yan, K. G., & García–Tsao, G. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1145663 · Cited by 26
Overview on acute-on-chronic liver failure
Zhang, J., Gao, S., Duan, Z., & Hu, K. (2016) · Frontiers of Medicine · doi:10.1007/s11684-016-0439-x · Cited by 26
Periodontal status of liver transplant candidates and healthy controls
Profio, B. D., Inoue, G., Marui, V. C., de França, B. N., Romito, G. A., Ortega, K. L., Holzhausen, M., & Pannuti, C. M. (2018) · Journal of Periodontology · doi:10.1002/jper.17-0710 · Cited by 26
Approach and management of dysnatremias in cirrhosis
Bernardi, M., & Zaccherini, G. (2018) · Hepatology International · doi:10.1007/s12072-018-9894-6 · Cited by 28
Self-citation
The impact of HBV flare on the outcome of HBV‐related decompensated cirrhosis patients with bacterial infection
Cao, Z., Liu, Y., Wang, S., Lu, X., Yin, S., Jiang, S., Chen, L., Cai, M., Zeng, B., Yao, Y., et al. (2019) · Liver International · doi:10.1111/liv.14176 · Cited by 26
Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study
Grensemann, J., Busse, D., König, C., Roedl, K., Jäger, W. R., Jarczak, D., Iwersen‐Bergmann, S., Manthey, C., Kluge, S., Kloft, C., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00666-8 · Cited by 26
The Gut‒Liver Axis in Liver Disease: Molecular Mechanisms and Therapeutic Targets
Chen, Z., Liao, S., Wu, S., Chen, S., Tang, Q., Zhou, L., Li, X., Hu, H., Xu, J., Zhang, A., et al. (2025) · MedComm · doi:10.1002/mco2.70458 · Cited by 29
The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure
Perdigoto, D., Figueiredo, P., & Tomé, L. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.7862 · Cited by 25
Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short‐Chain Fatty Acids in Experimental Cirrhosis
Juanola, O., Piñero, P., Gómez‐Hurtado, I., Caparrós, E., Garcı́a-Villalba, R., Marín, A., Zapater, P., Tarín, F., González-Navajas, J. M., Tomás-Barberán, F. A., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1268 · Cited by 25
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection
Ferrarese, A., Frigo, A. C., Mion, M. M., Plebani, M., Russo, F. P., Germani, G., Gambato, M., Cillo, U., Cattelan, A. M., Burra, P., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1212 · Cited by 25
Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era
Premkumar, M., Kajal, K., Kulkarni, A. V., Gupta, A., & Divyaveer, S. S. (2021) · Journal of Intensive Care Medicine · doi:10.1177/0885066620988281 · Cited by 25
Updated strategies in the management of acute variceal haemorrhage
Edelson, J. C., Basso, J. E., & Rockey, D. C. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000723 · Cited by 25
Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?
Piano, S. S., & Angeli, P. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.01.006 · Cited by 28
Self-citation
Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis
Kim, J. H., Jeon, Y. D., Jung, I. Y., Ahn, M. Y., Ahn, H. W., Ahn, J. Y., Ku, N. S., Han, S. H., Choi, J. Y., Ahn, S. H., et al. (2016) · Medicine · doi:10.1097/md.0000000000003489 · Cited by 25
Prevalence and predictors for spontaneous bacterial peritonitis in cirrhotic patients with ascites admitted at medical block in Korle-Bu Teaching Hospital, Ghana
Duah, A., & Nkrumah, K. N. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.33.35.18029 · Cited by 25
Clinical trial watch: Reports from the AASLD Liver Meeting®, Boston, November 2014
Londoño, M., Abraldeṣ, J. G., Altamirano, J., Decaens, T., & Forns, X. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.028 · Cited by 24
Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives
Fiore, M., Maraolo, A. E., Leone, S., Gentile, I., Cuomo, A., Schiavone, V., Bimonte, S., Pace, M. C., & Cascella, M. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s144262 · Cited by 24
Minimal/Covert Hepatic Encephalopathy – Impact of Comorbid Conditions
Weißenborn, K. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.08.010 · Cited by 27
Prediction of 28‐day mortality in acute decompensation of cirrhosis through the presence of multidrug‐resistant infections at admission
Gupta, T., Lochan, D., Verma, N., Rathi, S., Agrawal, S., Duseja, A. K., Taneja, S., Chawla, Y. K., & Dhiman, R. K. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14788 · Cited by 24
Loss of Coordinated Neutrophil Responses to the Human Fungal Pathogen, Candida albicans, in Patients With Cirrhosis
Knooihuizen, S. A. I., Alexander, N. J., Hopke, A. R., Barros, N., Viens, A. L., Scherer, A. K., Atallah, N. J., Dagher, Z., Irimia, D., Chung, R. T., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1645 · Cited by 24
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis
Liu, J., Macnaughtan, J., Kerbert, A. J. C., Portlock, T., González, J. M., Jin, Y., Clasen, F., Habtesion, A., Ji, H., Jin, Q., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-330699 · Cited by 23
Self-citation
Complications of cirrhosis. A 50 years flashback
Møller, S., & Bendtsen, F. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1021709 · Cited by 24
Chemical composition and evaluation of the antibacterial and Cytotoxic activities of the essential oil from the leaves of Myracrodruon urundeuva
de Araújo, Í. D. R., de Aquino, N. C., Guerra, A. C. V. D. A., Júnior, R. F. D. A., Araújo, R. M., Júnior, R. F. D. A., Farias, K. J. S., Fernandes, J. V., & Andrade, V. S. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1918-6 · Cited by 75
Spontaneous Bacterial Peritonitis
Song, D. S. (2018) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2018.72.2.56 · Cited by 23
Lymphocyte-to-monocyte ratio predicts mortality in cirrhotic patients with septic shock
Hsu, Y.-C., Yang, Y.-Y., & Tsai, I. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.11.071 · Cited by 23
Prostaglandin E2‐mediated immunosuppression and the role of albumin as its modulator
Choe, W. H., & Baik, S. K. (2014) · Hepatology · doi:10.1002/hep.27644 · Cited by 23
Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure
Engelmann, C., & Berg, T. (2018) · Visceral Medicine · doi:10.1159/000491107 · Cited by 25
Cirrhotic Patients Admitted to the ICU With Septic Shock: Factors Predicting Short and Long-Term Outcome
Baudry, T., Hernu, R., Valleix, B., Jahandiez, V., Faucher, E., Simon, M., Cour, M., & Argaud, L. (2018) · Shock · doi:10.1097/shk.0000000000001282 · Cited by 23
Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin
Marciano, S., Dirchwolf, M., Diaz, J. M., Bermúdez, C., Gutierrez‐Acevedo, M. N., Barcán, L., Smud, A., Giunta, D. H., & Gadano, A. C. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001331 · Cited by 24
Transpapillary Gallbladder Stents Can Stabilize or Improve Decompensated Cirrhosis in Patients Awaiting Liver Transplantation
Tujios, S. R., Rahnama‐Moghadam, S., Elmunzer, J. B., Kwon, R. S., Singal, A. G., Anderson, M. A., Wamsteker, E., Taylor, J. R., Scheiman, J. M., Elta, G. H., et al. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000269 · Cited by 23
Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study
Marciano, S., Haddad, L., Reggiardo, M. V., Peralta, M., Vistarini, C., Marino, M., Descalzi, V., D'Amico, C., Escuti, S. F., Gaite, L. A., et al. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25033 · Cited by 22
Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling
Zhu, J., Qiu, J., Chen, K., Wang, W., & Zheng, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111263 · Cited by 22
Step by Step: Managing the Complications of Cirrhosis
Pérez, I., Bolte, F. J., Bigelow, W. A., Dickson, Z., & Shah, N. L. (2021) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s278032 · Cited by 22
Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study
Johnson, A. L., Ratnasekera, I. U., Irvine, K. M., Henderson, A., Powell, E. E., & Valery, P. C. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000695 · Cited by 22
The impact of multidrug-resistant microorganisms on critically ill patients with cirrhosis in the intensive care unit: a cohort study
Kim, M., Cardoso, F. S., Pawlowski, A. E., Wunderink, R. G., Ladner, D. P., Abraldeṣ, J. G., & Karvellas, C. J. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000038 · Cited by 22
Bacterial infections in alcoholic and nonalcoholic liver cirrhosis
Sargenti, K., Prytz, H., Nilsson, E., Bertilsson, S., & Kalaitzakis, E. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000396 · Cited by 22
Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis
Zapater, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11493 · Cited by 22
Increased EMR2 expression on neutrophils correlates with disease severity and predicts overall mortality in cirrhotic patients
Huang, C., Jeng, W., Ho, Y., Teng, W., Hsieh, Y., Chen, W., Chen, Y., Lin, H.-H., Sheen, I., & Lin, C. (2016) · Scientific Reports · doi:10.1038/srep38250 · Cited by 22
Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options
Chen, D., Qian, Z., Su, H., Meng, Z., Lv, J., Huang, Y., Gao, Y., Liu, J., Zhao, C., Gao, H., et al. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00524-5 · Cited by 21
Outcomes of septic cirrhosis patients admitted to the intensive care unit
Chebl, R. B., Tamim, H., Sadat, M., Qahtani, S., Dabbagh, T., & Arabi, Y. M. (2021) · Medicine · doi:10.1097/md.0000000000027593 · Cited by 20
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Kremer, W. M., Gairing, S. J., Kaps, L., Ismail, E., Kalampoka, V., Hilscher, M., Michel, M. S., Siegel, E., Schattenberg, J. M., Galle, P. R., et al. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100719 · Cited by 20
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study” (EABCIR-Global Study)
Maiwall, R., Piano, S. S., Singh, V., Caraceni, P., Alessandria, C., Fernández, J., Soares, E. C., Kim, D. J., Kim, S. E., Marino, M., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000653 · Cited by 21
Self-citation
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease
Brandolini, M., Corbella, M., Silvestri, A. D., Tinelli, C., Albonico, G., Albertini, R., Ludovisi, S., Bruno, R., Marone, P., Minoli, L., et al. (2015) · Infection · doi:10.1007/s15010-015-0794-6 · Cited by 21
Future therapy of portal hypertension in liver cirrhosis – a guess
Sauerbruch, T., & Trebicka, J. (2014) · F1000Prime Reports · doi:10.12703/p6-95 · Cited by 21
Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis
Lutz, P. L., Goeser, F., Kaczmarek, D. J., Schlabe, S., Nischalke, H. D., Nattermann, J., Hoerauf, A. M., Strassburg, C. P., & Spengler, U. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4637-4 · Cited by 21
Bacterial Infection in Patients with Cirrhosis: Don’t Get Bugged to Death
Cannon, M. D., Martin, P. B., & Carrion, A. F. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05943-6 · Cited by 21
Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections
Chen, T., Chen, G., Wang, G., Treeprasertsuk, S., Lesmana, C. R. A., Lin, H., Al‐Mahtab, M., Chawla, Y. K., Tan, S.-S., Kao, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10637-3 · Cited by 24
Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis
Swift, O., Sharma, S., Ramanarayanan, S., Umar, H., Laws, K. R., Vilar, E., & Farrington, K. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab230 · Cited by 20
Impact of gut microbiota on liver transplantation
Sucu, S., Basarir, K. E., Mihaylov, P. V., Balık, E., Lee, J. T. C., Fridell, J. A., Emamaullee, J. A., & Ekser, B. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.05.030 · Cited by 20
Proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhosis: An undesirable association?
Miozzo, S. A. D. S., Tovo, C. V., John, J. A., & de Mattos, Â. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.041 · Cited by 20
Bacterial Infections in Patients with Liver Cirrhosis in an Internal Medicine Department
Gomes, C. L., Silva, R. V., Carrola, P., & Presa, J. (2018) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000494568 · Cited by 20
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
Zaccherini, G., Baldassarre, M., Bartoletti, M., Tufoni, M., Berardi, S., Tamè, M., Napoli, L., Siniscalchi, A., Fabbri, A., Marconi, L., et al. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.005 · Cited by 20
Self-citation
Acute-on-Chronic Liver Failure in Budd–Chiari Syndrome: Profile and Predictors of Outcome
Shalimar, S., Sharma, S., Gamanagatti, S. R., Chauhan, A. K., Vuyyuru, S. K., Elhence, A., Rout, G., Saraya, A., Gunjan, D., Nayak, B., et al. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-06005-7 · Cited by 20
Organ System Network Disruption Is Associated With Poor Prognosis in Patients With Chronic Liver Failure
Tan, Y. Y., Montagnese, S., & Mani, A. R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00983 · Cited by 21

Authors: Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., Albillos, A., Lammert, F., Wilmer, A., Mookerjee, R., Vila, J., Garcia-Martinez, R., Wendon, J., Such, J., Cordoba, J., Sanyal, A., Garcia-Tsao, G., Arroyo, V., Burroughs, A., & Ginès, P.
Affiliations: The Royal Free Hospital (GB)
University Hospital of Bern (CH)
University of California San Diego (US)
Inserm (FR)
University of Padua (IT)
Medical University of Graz (AT)
Université Libre de Bruxelles (BE)
University of Bologna (IT)
Universitätsklinikum des Saarlandes (DE)
Universitair Ziekenhuis Leuven (BE)
King's College London (GB)
Instituto de Salud Carlos III (ES)
Virginia Commonwealth University (US)
Corresponding author: Ginès, Pere
ORCID: Jalan, Rajiv
Wiest, Reiner
Schnabl, Bernd
Moreau, Richard
Angeli, Paolo
Stadlbauer, Vanessa
Gustot, Thierry
Bernardi, Mauro
Lammert, Frank
Wilmer, Alexander
Mookerjee, Rajeshwar
Wendon, Julia
Such, José
Sanyal, Arun
Arroyo, Vicente
Burroughs, Andrew
Ginès, Pere
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2014-06
Volume: 60
Issue: 6
Pages: 1310-1324
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2014.01.024
OpenAlex: W2136919496
Cited by: 906
References: 165
Citations by year: 2026: 35 · 2025: 52 · 2024: 63 · 2023: 56 · 2022: 88 · 2021: 105 · 2020: 83 · 2019: 79 · 2018: 102 · 2017: 84 · 2016: 72 · 2015: 65 · 2014: 22
FWCI: 45.19
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Journal of Hepatology (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
BORIS (University Library Bern) (submittedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
UCL Discovery (University College London) (submittedVersion)
Research Portal (King's College London) (submittedVersion, other-oa)
Lirias (KU Leuven) (submittedVersion, cc-by-nc-nd)
Padua Research Archive (University of Padova) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
Funders: Fondo de Investigación Sanitaria (FIS PI08/0126, FIS PI12/00330)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: bacterial infection, liver cirrhosis, immune dysfunction, Gram-negative bacteria, Gram-positive bacteria, multidrug-resistant bacteria, infection control, antibiotic prophylaxis, gut microbiota, bacterial translocation, acute-on-chronic liver failure, infection biomarkers, early infection detection, hospitalization
MeSH terms: Anti-Bacterial Agents, Bacterial Infections, Gastroenterology, Humans, Liver Cirrhosis, Practice Guidelines as Topic, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks